Where I see patients (1)
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
Silencing tau to treat early Alzheimer's disease.
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome.
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Assess adverse events during 6 months administration of Verdiperstat or Placebo